September 12, 2018
DataSpace @ virtual HIV R4P: 3 February 2021
We are excited to announce that we will be running a virtual satellite session at HIV R4P. In this satellite session you will hear from global leaders in the field of data architecture and visualization platforms and big data science on how these solutions can be applied to have the maximum cross-functional impact in 3 key areas: 1) understanding target populations for vaccine campaigns 2) vaccine design strategies and 3) predictors of the outcomes of vaccination.
VISTA meeting in Nairobi, Kenya (September/October 2019)
VISTA (Vaccine Immunology Science and Technology for Africa) partners and postdoctoral fellows will be meeting in Nairobi, Kenya between 30 September and 2 October 2019. VISTA consortia brings together clinical research centres from five African countries with the focus on developing vaccine candidates and assessing the immune responses they induce. The VISTA members will be discussing some of the outcomes of their work around T cell and B cell immunogen design as well as firming up plans for the work ahead.
Check out a recent publication on KIRs in HIV that was supported by Protocol C samples
Researchers studied a well-characterized cohort of HIV-1 seroconverters from sub-Saharan Africa who were identified when seronegative and followed under Protocol C of the International AIDS Vaccine Initiative (IAVI). iKIR genes enhance the protective effect of HLA-B*57 on early set-point viral load and time to low CD4 count. The full paper is available in November 2018 Science Immunology.